Figure 4 | Scientific Reports

Figure 4

From: Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay

Figure 4

High levels of CASP8 are associated with worse outcome in renal cancer. (A) mRNA levels of CASP8 in recurrent renal cancer vs non-recurrent renal cancer patients were plotted (TCGA, PanCancer Atlas, 2018). Disease free survival curve was plotted. (B) Disease specific survival curve of patients with CASP8 high or CASP8 low expression was shown. (C) Overall survival of patients with CASP8 high or CASP8 low expression was presented. All RNA-Seq data sets were extracted from cBioPortal and presented as mRNA Z-score.

Back to article page